PatientsVille.com Logo

Kenacort Side Effects

PatientsVille

Common Kenacort Side Effects


The most commonly reported Kenacort side effects (click to view or check a box to report):

Scleral Thinning (8)
Endophthalmitis (8)
Cytomegalovirus Chorioretinitis (8)
Retinal Artery Occlusion (7)
Retinal Detachment (6)
Glaucoma (5)
Adverse Event (5)
Anaphylactic Reaction (5)
Retinal Pigment Epitheliopathy (5)
Muscle Atrophy (5)
Intraocular Pressure Increased (5)
Atrophy (4)
Anaphylactic Shock (4)
Conjunctival Haemorrhage (4)
Anaphylactoid Reaction (4)
Injection Site Atrophy (4)
Paraesthesia (4)
Pain (4)
Haemarthrosis (4)
Necrotising Scleritis (3)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Kenacort Side Effects Reported to FDA



Kenacort Side Effect Report#9964257
Petit Mal Epilepsy
This is a report of a 75-year-old female patient (weight: NA) from NL, suffering from the following health symptoms/conditions: periarthritis,osteoporosis, who was treated with Kenacort-a40 Inj 40 Mg (dosage: NA, start time:
Nov 11, 2005), combined with:
  • Teriparatide (1 Df=20 Mcg/ml Inj Fluid)
  • Depakine
  • Lidocaine
  • Phenobarbital Sodium
  • Ethosuximide
  • Calcichew (1 Df=500mg/400ie ?chewing Tablet)
  • Plaquenil Sulfate
  • Alendronic Acid
and developed a serious reaction and side effect(s): Petit Mal Epilepsy after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Kenacort-a40 Inj 40 Mg treatment in female patients, resulting in Petit Mal Epilepsy side effect.
Kenacort Side Effect Report#9774159
Lipodystrophy Acquired, Injection Site Reaction
This report suggests a potential Kenacort Inj Lipodystrophy Acquired side effect(s) that can have serious consequences. A 57-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Kenacort Inj (dosage: NA) starting 2012. After starting Kenacort Inj the patient began experiencing various side effects, including: Lipodystrophy Acquired, Injection Site ReactionAdditional drugs used concurrently: NA. Although Kenacort Inj demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Lipodystrophy Acquired, may still occur.
Kenacort Side Effect Report#9770750
Optic Neuritis
This Optic Neuritis problem was reported by a health professional from JP. A 50-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: macular oedema. On NS this consumer started treatment with Kenacort-a Inj (dosage: Intravitreal Injection). The following drugs were being taken at the same time: NA. When using Kenacort-a Inj, the patient experienced the following unwanted symptoms/side effects: Optic NeuritisThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Optic Neuritis, may become evident only after a product is in use by the general population.
Kenacort Side Effect Report#9767828
Overdose, Cushing^s Syndrome
This Overdose side effect was reported by a health professional from IT. A 37-year-old patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Kenacort (drug dosage: Formu:40mg/ml), which was initiated on NS. Concurrently used drugs: NA..After starting to take Kenacort the consumer reported adverse symptoms, such as: Overdose, Cushing^s SyndromeThese side effects may potentially be related to Kenacort.
Kenacort Side Effect Report#9755907
Hypoglycaemic Unconsciousness, Hypoglycaemia, Hyperglycaemia
This is a report of a 43-year-old female patient (weight: NA) from NL, suffering from the following health symptoms/conditions: arthralgia, who was treated with Kenacort-a40 Inj (dosage: Suspension 40mg/ml 1ml Flask, start time: 1978), combined with:
  • Humalog (Injection Fluid 100e/ml 10ml Flask)
and developed a serious reaction and side effect(s): Hypoglycaemic Unconsciousness, Hypoglycaemia, Hyperglycaemia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Kenacort-a40 Inj treatment in female patients, resulting in Hypoglycaemic Unconsciousness side effect.
Kenacort Side Effect Report#9751899
Csf Pressure Decreased, Headache, Paraesthesia
This report suggests a potential Kenacort Inj 40 Mg/ml Csf Pressure Decreased side effect(s) that can have serious consequences. A 36-year-old male patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: NA and used Kenacort Inj 40 Mg/ml (dosage: 1df=40 Mg/ml Inj Sol?1-unit/total) starting
Nov 11, 2013. After starting Kenacort Inj 40 Mg/ml the patient began experiencing various side effects, including: Csf Pressure Decreased, Headache, ParaesthesiaAdditional drugs used concurrently:
  • Lidocaine Hcl (1df=1-unit/total)
The patient was hospitalized. Although Kenacort Inj 40 Mg/ml demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Csf Pressure Decreased, may still occur.
Kenacort Side Effect Report#9751894
Cushing^s Syndrome
This Cushing^s Syndrome problem was reported by a physician from IT. A 37-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Kenacort-a (dosage: NA). The following drugs were being taken at the same time: NA. When using Kenacort-a, the patient experienced the following unwanted symptoms/side effects: Cushing^s SyndromeAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cushing^s Syndrome, may become evident only after a product is in use by the general population.
Kenacort Side Effect Report#9749710
Diverticulitis, Retinal Pigment Epitheliopathy, Systolic Hypertension
This Diverticulitis side effect was reported by a consumer or non-health professional from FR. A 49-year-old female patient (weight:NA) experienced the following symptoms/conditions: nasal polyps,diverticulitis.The patient was prescribed Kenacort Inj (drug dosage: NA), which was initiated on
Sep 06, 2013. Concurrently used drugs:
  • Azactam For Inj 1 Gm (Last Dose: 19sep2013)
  • Metronidazole (Last Dose: 19sep2013)
.After starting to take Kenacort Inj the consumer reported adverse symptoms, such as: Diverticulitis, Retinal Pigment Epitheliopathy, Systolic HypertensionThese side effects may potentially be related to Kenacort Inj. The patient was hospitalized.
Kenacort Side Effect Report#9744146
Oesophageal Perforation
This is a report of a 55-year-old male patient (weight: NA) from JP, suffering from the following health symptoms/conditions: anastomotic stenosis, who was treated with Kenacort-a Inj (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Oesophageal Perforation after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Kenacort-a Inj treatment in male patients, resulting in Oesophageal Perforation side effect.
Kenacort Side Effect Report#9744106
Oesophageal Perforation
This report suggests a potential Kenacort-a Inj Oesophageal Perforation side effect(s) that can have serious consequences. A 67-year-old male patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: anastomotic stenosis and used Kenacort-a Inj (dosage: Kenacort-a Inj) starting NS. After starting Kenacort-a Inj the patient began experiencing various side effects, including: Oesophageal PerforationAdditional drugs used concurrently: NA. Although Kenacort-a Inj demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Oesophageal Perforation, may still occur.
Kenacort Side Effect Report#9706541
Retinal Detachment
This Retinal Detachment problem was reported by a health professional from JP. A 40-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: macular oedema,detachment of retinal pigment epithelium. On NS this consumer started treatment with Kenacort-a Inj (dosage: Subcapsular Injection). The following drugs were being taken at the same time: NA. When using Kenacort-a Inj, the patient experienced the following unwanted symptoms/side effects: Retinal DetachmentAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Retinal Detachment, may become evident only after a product is in use by the general population.
Kenacort Side Effect Report#9672404
Oesophageal Perforation, Pneumomediastinum, Paraoesophageal Abscess
This Oesophageal Perforation side effect was reported by a health professional from JP. A 60-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Kenacort-a Inj 40 Mg/ml (drug dosage: 1ml:10mg Of 40mg/5ml,injected In To Submucosa), which was initiated on NS. Concurrently used drugs: NA..After starting to take Kenacort-a Inj 40 Mg/ml the consumer reported adverse symptoms, such as: Oesophageal Perforation, Pneumomediastinum, Paraoesophageal AbscessThese side effects may potentially be related to Kenacort-a Inj 40 Mg/ml. The patient was hospitalized.
Kenacort Side Effect Report#9654707
Nerve Injury, Neuralgia, Paralysis
This is a report of a 58-year-old male patient (weight: NA) from NL, suffering from the following health symptoms/conditions: sacroiliitis, who was treated with Kenacort (dosage: 21-aug-2013, start time:
Aug 21, 2013), combined with:
  • Diclofenac Potassium Tabs 50 Mg
  • Paracetamol Tabs 500 Mg (1 Df: 2 Tabs)
and developed a serious reaction and side effect(s): Nerve Injury, Neuralgia, Paralysis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Kenacort treatment in male patients, resulting in Nerve Injury side effect.
Kenacort Side Effect Report#9549503
Cerebral Haemorrhage
This report suggests a potential Kenacort-a Inj 10 Mg/ml Cerebral Haemorrhage side effect(s) that can have serious consequences. A 77-year-old male patient (weight: NA) from NL was diagnosed with the following symptoms/conditions: NA and used Kenacort-a Inj 10 Mg/ml (dosage: NA) starting 2008. After starting Kenacort-a Inj 10 Mg/ml the patient began experiencing various side effects, including: Cerebral HaemorrhageAdditional drugs used concurrently:
  • Acenocoumarol
The patient was hospitalized. Although Kenacort-a Inj 10 Mg/ml demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Cerebral Haemorrhage, may still occur.
Kenacort Side Effect Report#9454644
Cubital Tunnel Syndrome
This Cubital Tunnel Syndrome problem was reported by a health professional from JP. A 63-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: epicondylitis. On NS this consumer started treatment with Kenacort-a Inj (dosage: NA). The following drugs were being taken at the same time: NA. When using Kenacort-a Inj, the patient experienced the following unwanted symptoms/side effects: Cubital Tunnel SyndromeAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cubital Tunnel Syndrome, may become evident only after a product is in use by the general population.
Kenacort Side Effect Report#9454643
Cubital Tunnel Syndrome
This Cubital Tunnel Syndrome side effect was reported by a health professional from JP. A 40-year-old male patient (weight:NA) experienced the following symptoms/conditions: epicondylitis.The patient was prescribed Kenacort-a Inj (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Kenacort-a Inj the consumer reported adverse symptoms, such as: Cubital Tunnel SyndromeThese side effects may potentially be related to Kenacort-a Inj.
Kenacort Side Effect Report#9410608
Articular Calcification
This is a report of a 51-year-old female patient (weight: NA) from JP, suffering from the following health symptoms/conditions: rheumatoid arthritis, who was treated with Kenacort-a Inj (dosage: No Of Inj:22, start time: NS), combined with:
  • Methotrexate
  • Abatacept
and developed a serious reaction and side effect(s): Articular Calcification after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Kenacort-a Inj treatment in female patients, resulting in Articular Calcification side effect.
Kenacort Side Effect Report#9410598
Articular Calcification
This report suggests a potential Kenacort-a Inj Articular Calcification side effect(s) that can have serious consequences. A 58-year-old female patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: rheumatoid arthritis and used Kenacort-a Inj (dosage: No Of Inj:22) starting NS. After starting Kenacort-a Inj the patient began experiencing various side effects, including: Articular CalcificationAdditional drugs used concurrently:
  • Methotrexate
  • Infliximab
  • Prednisone
Although Kenacort-a Inj demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Articular Calcification, may still occur.
Kenacort Side Effect Report#9403700
Cytomegalovirus Chorioretinitis, Hypopyon
This Cytomegalovirus Chorioretinitis problem was reported by a health professional from JP. A 75-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: macular oedema. On
Oct 11, 2007 this consumer started treatment with Kenacort-a Inj (dosage: Intraocular(vitreous Injection) On 05sep07: 4mg?intraocular(sub-tennon) On 10sep07: 12mg). The following drugs were being taken at the same time:
  • Cravit
  • Diclod
  • Flumetholon
When using Kenacort-a Inj, the patient experienced the following unwanted symptoms/side effects: Cytomegalovirus Chorioretinitis, HypopyonThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cytomegalovirus Chorioretinitis, may become evident only after a product is in use by the general population.
Kenacort Side Effect Report#9241166
Tenosynovitis
This Tenosynovitis side effect was reported by a consumer or non-health professional from JP. A 52-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Kenacort Inj 10 Mg/ml (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Kenacort Inj 10 Mg/ml the consumer reported adverse symptoms, such as: TenosynovitisThese side effects may potentially be related to Kenacort Inj 10 Mg/ml.
Kenacort Side Effect Report#8798999
Suppressed Lactation
This is a report of a 35-year-old female patient (weight: NA) from AU, suffering from the following health symptoms/conditions: spinal pain, who was treated with Kenacort (dosage: 1df:80-120mg (total Dose). Injection., start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Suppressed Lactation after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Kenacort treatment in female patients, resulting in Suppressed Lactation side effect.
Kenacort Side Effect Report#8719252
Injection Site Atrophy, Muscle Atrophy
This report suggests a potential Kenacort Retard 80 Inj Injection Site Atrophy side effect(s) that can have serious consequences. A 61-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Kenacort Retard 80 Inj (dosage: NA) starting 201108. After starting Kenacort Retard 80 Inj the patient began experiencing various side effects, including: Injection Site Atrophy, Muscle AtrophyAdditional drugs used concurrently: NA. Although Kenacort Retard 80 Inj demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Injection Site Atrophy, may still occur.
Kenacort Side Effect Report#8633354
Anaphylactic Shock, Urticaria, Gamma-glutamyltransferase Decreased
This Anaphylactic Shock problem was reported by a consumer or non-health professional from JP. A 70-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: trigger finger. On
Jan 15, 2011 this consumer started treatment with Kenacort (dosage: Route:intra Tendon Inj). The following drugs were being taken at the same time:
  • Xylocaine (Route:intra Tendon Inj)
  • Ursodeoxycholic Acid (Tab)
  • Atenolol Tabs
  • Unisia (1df=8mg + 5mg)
  • Crestor (Tab)
When using Kenacort, the patient experienced the following unwanted symptoms/side effects: Anaphylactic Shock, Urticaria, Gamma-glutamyltransferase DecreasedThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Anaphylactic Shock, may become evident only after a product is in use by the general population.
Kenacort Side Effect Report#8419779-7
Blood Cortisol Decreased, Diabetes Mellitus, Hypertension, Hyperglycaemia, Cushingoid, Cushing's Syndrome
This Blood Cortisol Decreased side effect was reported by a pharmacist from Switzerland. A 39-year-old female patient (weight:NA) experienced the following symptoms/conditions: back pain,osteoporosis,hiv infection.The patient was prescribed Kenacort-a Ophthalmic Ointment (drug dosage: One Single Administration), which was initiated on
Jan 01, 2011. Concurrently used drugs:
  • Calcimagon-d3
  • Norvir
  • Prezista
  • Truvada
  • Rasilez
.After starting to take Kenacort-a Ophthalmic Ointment the consumer reported adverse symptoms, such as: Blood Cortisol Decreased, Diabetes Mellitus, Hypertension, Hyperglycaemia, Cushingoid, Cushing's SyndromeThese side effects may potentially be related to Kenacort-a Ophthalmic Ointment.
Kenacort Side Effect Report#8373030-5
Retinal Artery Occlusion, Anaphylactoid Reaction
This is a report of a 51-year-old female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: sinusitis, who was treated with Kenacort (dosage: 1df= 40 Mg/1 Ml, start time:
Nov 24, 2011), combined with: NA. and developed a serious reaction and side effect(s): Retinal Artery Occlusion, Anaphylactoid Reaction after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Kenacort treatment in female patients, resulting in Retinal Artery Occlusion side effect. The patient was hospitalized.


1 of 8 


The appearance of Kenacort on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.


Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Kenacort reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Kenacort Side Effects

    Did You Have a Kenacort Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Kenacort for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective